Swapnil Jatin Shah & Others Acquire 11,70,000 Convertible Equity Warrants in Senores Pharmaceuticals Ltd

Swapnil Jatin Shah and others, all promoters and promoter group of Senores Pharmaceuticals Limited, have disclosed the allotment of 11,70,000 convertible equity warrants on a preferential basis to the allottees. This disclosure is in compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquirers and persons acting in concert (PAC) include Swapnil Jatin Shah, Renosen Pharmaceuticals Private Limited, Ashokbhai Vijaysinh Barot, Sangeeta Mukur Barot, and Viraj Ashokkumar Barot. The warrants were allotted on March 28, 2026, and the equity share capital of the company remains unchanged at ₹46,05,35,880 consisting of 4,60,53,588 equity shares with a face value of ₹ 10/-. The total diluted share/voting capital of the company after the acquisition is ₹47,22,35,880 consisting of 4,72,23,588 equity shares.